NTRK1 and glioblastoma: Large-scale genomic analyses of GBM have demonstrated that the RTK (receptor tyrosine kinases)/phosphatase and tensin homolog (PTEN)/PI3K/AKT pathway is mutated or overly activated in the majority of GBM subtypes.